Two cases of late-onset secondary adrenal insufficiency after discontinuation of nivolumab

Kohei Otsubo; K. Nakatomi; R. Furukawa; K. Ashida; Y. Yoneshima; Yoichi Nakanishi; I. Okamoto

doi:10.1093/annonc/mdx497

Two cases of late-onset secondary adrenal insufficiency after discontinuation of nivolumab

Kohei Otsubo, K. Nakatomi, R. Furukawa, K. Ashida, Y. Yoneshima, Yoichi Nakanishi, I. Okamoto

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	3106-3107
Number of pages	2
Journal	Annals of Oncology
Volume	28
Issue number	12
DOIs	https://doi.org/10.1093/annonc/mdx497
Publication status	Published - Dec 1 2017

All Science Journal Classification (ASJC) codes

Hematology
Oncology

Access to Document

10.1093/annonc/mdx497

Cite this

@article{56d7aa34aef2444fa3071f27b5e2c0b2,

title = "Two cases of late-onset secondary adrenal insufficiency after discontinuation of nivolumab",

author = "Kohei Otsubo and K. Nakatomi and R. Furukawa and K. Ashida and Y. Yoneshima and Yoichi Nakanishi and I. Okamoto",

year = "2017",

month = dec,

day = "1",

doi = "10.1093/annonc/mdx497",

language = "English",

volume = "28",

pages = "3106--3107",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - Two cases of late-onset secondary adrenal insufficiency after discontinuation of nivolumab

AU - Otsubo, Kohei

AU - Nakatomi, K.

AU - Furukawa, R.

AU - Ashida, K.

AU - Yoneshima, Y.

AU - Nakanishi, Yoichi

AU - Okamoto, I.

PY - 2017/12/1

Y1 - 2017/12/1

UR - http://www.scopus.com/inward/record.url?scp=85042153213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042153213&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdx497

DO - 10.1093/annonc/mdx497

M3 - Letter

C2 - 28945828

AN - SCOPUS:85042153213

VL - 28

SP - 3106

EP - 3107

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 12

ER -

Two cases of late-onset secondary adrenal insufficiency after discontinuation of nivolumab

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this